Beryl Drugs (BOM:524606) Total Liabilities : ₹85.6 Mil (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Beryl Drugs Total Liabilities?

Beryl Drugs's Total Liabilities for the quarter that ended in Mar. 2024 was ₹85.6 Mil.

Beryl Drugs's quarterly Total Liabilities declined from Sep. 2023 (₹102.63 Mil) to Dec. 2023 (₹0.00 Mil) but then increased from Dec. 2023 (₹0.00 Mil) to Mar. 2024 (₹85.63 Mil).

Beryl Drugs's annual Total Liabilities declined from Mar. 2022 (₹105.30 Mil) to Mar. 2023 (₹94.45 Mil) and declined from Mar. 2023 (₹94.45 Mil) to Mar. 2024 (₹85.63 Mil).

Beryl Drugs Total Liabilities Historical Data

The historical data trend for Beryl Drugs's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beryl Drugs Total Liabilities Chart

Beryl Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

92.86

107.19

105.30

94.45

85.63

Beryl Drugs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															94.45	-	102.63	-	85.63

Beryl Drugs Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Beryl Drugs's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	57.554	+	(24.038	+	4.037
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	85.6

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	174.862	-	89.233
	=	85.6

Beryl Drugs's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	57.554	+	(24.038	+	4.037
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	85.6

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	174.862	-	89.233
	=	85.6

Beryl Drugs Total Liabilities Related Terms

Thank you for viewing the detailed overview of Beryl Drugs's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Beryl Drugs (BOM:524606) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beryl Drugs Ltd (BOM:524606) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

133, Kanchan Bagh, Ground Floor, Indore, MP, IND, 452001

Website

http://www.beryldrugs.com

Beryl Drugs Ltd is a pharmaceutical company principally engaged in the manufacturing and marketing of allopathic pharmaceutical preparations. It also provides contract manufacturing services and veterinary products. It offers manufacturing options for product requirements like small-volume injectables in liquid form, small-volume injectables in dry powder form, eye and ear drops, intravenous fluids in poly pack and glass bottles, and veterinary medicines. The company earns the majority of its revenue from the sale of Bulk Drugs.

Beryl Drugs (BOM:524606) Headlines

No Headlines